Click here to go to the previous page
Recognition & Management of Atypical Forms of Diabetes
Program Code:
S78
SPEAKER
(S):
Samuel Joseph Casella, MD, Dartmouth Hitchcock Med Ctr
Disclosures: SJC: Study Investigator, Eli Lilly & Company, Novo Nordisk, Pfizer, Inc.
Siri Atma W Greeley, MD,PHD, Univ of Chicago
Disclosure: Nothing to Disclose
Stephen Colgan Clement, MD, Georgetown University
Disclosure: Nothing to Disclose
No items are available for this session.